Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Halozyme Therapeutics, Inc. | HALO | 33.25K | $2.6M |
EQT Corporation | EQT | 34.62K | $1.84M |
Lam Research Corporation | LRCX | 35K | $15.17M |
Protagonist Therapeutics, Inc. | PTGX | 35.02K | $4.29M |
4D Molecular Therapeutics, Inc. | FDMT | 48.51K | $645.12K |
Alkermes plc | ALKS | 50K | $2.62M |
uniQure N.V. | QURE | 50.7K | $2.34M |
Phathom Pharmaceuticals, Inc. | PHAT | 55K | $596.75K |
Corcept Therapeutics Incorporated | CORT | 57.2K | $4.97M |
Vera Therapeutics, Inc. | VERA | 57.76K | $2.48M |
BioAge Labs Inc. | BIOA | 69K | $1.69M |
Celldex Therapeutics, Inc. | CLDX | 69.9K | $2.6M |
Nektar Therapeutics | NKTR | 81K | $5.65M |
Zenas BioPharma, Inc. | ZBIO | 93.6K | $2.38M |
Ovintiv Inc. | OVV | 107.5K | $5.66M |
Altimmune, Inc. | ALT | 152.68K | $464.15K |
ACADIA Pharmaceuticals Inc. | ACAD | 171K | $4.33M |
Stoke Therapeutics, Inc. | STOK | 178.11K | $5.83M |
KLA Corporation | KLAC | 178.47K | $53.85M |
Olema Pharmaceuticals, Inc. | OLMA | 199K | $2.49M |